Insider Trading - Viridian Therapeutics Inc. (VRDN)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-09 Purchase | 2020-11-16 6:23 pm | MIRAGEN THERAPEUTICS Inc | MGEN | Logos Global Master Fund LP 10% Owner | 476,667 | $4.7632 | $2,270,484 | 550,000 (Direct) | View |
| 2021-09-21 Purchase | 2021-09-23 09:30 am | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner | 909,000 | $11 | $9,999,000 | 938,233 (Indirect) | View |
| 2021-09-23 Purchase | 2021-09-28 7:46 pm | Viridian Therapeutics Inc. | VRDN | Frazier Life Sciences Public Fund L.P. FHMLSP L.P. FHMLSP L.L.C. 10% Owner | 200,000 | $11 | $2,200,000 | 1,505,200 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-19 Option Award | 2019-06-21 5:17 pm | N/A 2029-06-18 | MIRAGEN THERAPEUTICS Inc | MGEN | Morris Arlene Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 5:18 pm | N/A 2029-06-18 | MIRAGEN THERAPEUTICS Inc | MGEN | TURNER JOSEPH L Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2019-08-23 Exercise | 2019-08-23 6:16 pm | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Leverone Jason A. CFO | 3,093 | $0.57 | 36,330 (Direct) | View |
| 2019-08-23 Exercise | 2019-08-23 6:16 pm | N/A 2019-09-23 | MIRAGEN THERAPEUTICS Inc | MGEN | Leverone Jason A. CFO | 3,093 | $0 | 0 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 6:18 pm | N/A 2030-02-11 | MIRAGEN THERAPEUTICS Inc | MGEN | Marshall William Stuart CEO | 464,000 | $0 | 464,000 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 6:21 pm | N/A 2030-02-11 | MIRAGEN THERAPEUTICS Inc | MGEN | Leverone Jason A. CFO | 185,000 | $0 | 185,000 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 6:24 pm | N/A 2030-02-11 | MIRAGEN THERAPEUTICS Inc | MGEN | Escolar Diana Chief Medical Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-17 4:22 pm | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Leverone Jason A. CFO | 11,249 | $0.57 | 48,829 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-17 4:22 pm | N/A 2020-03-15 | MIRAGEN THERAPEUTICS Inc | MGEN | Leverone Jason A. CFO | 11,249 | $0 | 0 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 5:09 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS Inc | MGEN | Bowden Christopher Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 5:13 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS Inc | MGEN | Hughes Thomas E. Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 5:16 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS Inc | MGEN | KOCH KEVIN Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 5:18 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS Inc | MGEN | Morris Arlene Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 5:21 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS Inc | MGEN | TURNER JOSEPH L Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 5:35 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS Inc | MGEN | Hatfield Jeffrey S. Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-09-14 Option Award | 2020-09-15 9:45 pm | 2020-10-14 2030-09-13 | MIRAGEN THERAPEUTICS Inc | MGEN | Rauch Lee M. CEO | 900,000 | $0 | 900,000 (Direct) | View |
| 2020-09-13 Option Award | 2020-09-17 5:31 pm | 2020-10-13 2020-09-12 | MIRAGEN THERAPEUTICS Inc | MGEN | Rauch Lee M. CEO | 900,000 | $0 | 900,000 (Direct) | View |
| 2020-10-27 Other | 2020-10-29 11:30 am | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 87,891 | $0 | 87,891 (Indirect) | View |
| 2020-10-27 Other | 2020-10-29 11:30 am | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 438,502 | $0 | 438,502 (Indirect) | View |
| 2020-10-27 Other | 2020-10-29 11:30 am | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 16,505 | $0 | 16,505 (Indirect) | View |
| 2020-10-27 Other | 2020-10-29 11:30 am | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 82,349 | $0 | 82,349 (Indirect) | View |
| 2020-10-27 Option Award | 2020-10-29 5:16 pm | N/A 2030-10-26 | MIRAGEN THERAPEUTICS Inc | MGEN | Kiselak Tomas Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-29 5:19 pm | N/A 2030-10-26 | MIRAGEN THERAPEUTICS Inc | MGEN | Harwin Peter Evan Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-10-30 Purchase | 2020-10-30 11:53 am | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 5,494 | $465.96 | 21,999 (Indirect) | View |
| 2020-10-30 Purchase | 2020-10-30 11:53 am | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 28,843 | $465.96 | 111,192 (Indirect) | View |
| 2020-10-27 Other | 2020-10-30 6:57 pm | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Violin Jonathan COO | 50,124 | $0 | 50,124 (Direct) | View |
| 2020-10-27 Other | 2020-10-30 6:57 pm | N/A 2030-09-23 | MIRAGEN THERAPEUTICS Inc | MGEN | Violin Jonathan COO | 4,338,079 | $0 | 4,338,079 (Direct) | View |
| 2020-10-27 Other | 2020-10-30 6:57 pm | N/A N/A | MIRAGEN THERAPEUTICS Inc | MGEN | Violin Jonathan COO | 9,413 | $0 | 9,413 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 8:04 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | MGEN | Rauch Lee M. See Remarks | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-18 Option Award | 2021-01-20 3:48 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Violin Jonathan CEO | 800,075 | $0 | 800,075 (Direct) | View |
| 2021-01-18 Option Award | 2021-01-20 3:55 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Leverone Jason A. CFO | 311,785 | $0 | 311,785 (Direct) | View |
| 2021-01-18 Option Award | 2021-01-21 7:33 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 356,000 | $0 | 356,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:38 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Morris Arlene Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:40 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:40 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:40 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Hatfield Jeffrey S. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:41 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | TURNER JOSEPH L Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-16 6:26 pm | N/A 2031-06-03 | Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-16 6:27 pm | N/A 2031-06-03 | Viridian Therapeutics Inc. | VRDN | Morris Arlene Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-16 6:34 pm | N/A 2031-06-03 | Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-15 4:24 pm | N/A 2031-07-14 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-07-26 Option Award | 2021-07-27 5:02 pm | N/A 2031-07-26 | Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO | 360,000 | $0 | 360,000 (Direct) | View |